We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Balchem Corp (BCPC) USD0.0666

Sell:$125.96 Buy:$126.31 Change: $0.41 (0.32%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.41 (0.32%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.41 (0.32%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company has three segments: Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also serves the food and beverage industry for beverage, bakery, dairy, confectionary and savory manufacturers. ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to basic choline chloride. The segment also manufactures and supplies choline chloride. Its Specialty products provides specialty-packaged chemicals for use in healthcare. The Company also manufactures specialty vitamin K2 for the human nutrition industry.

Contact details

52 Sunrise Park Rd,
P O Box 600
United States
+1 (845) 3265632

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$4.07 billion
Shares in issue:
32.12 million
Specialty Chemicals
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Theodore Harris
    Chairman of the Board, President, Chief Executive Officer
  • Martin Bengtsson
    Chief Financial Officer
  • James Hyde
    Senior Vice President, General Manager - Human Nutrition, Health segment
  • William Backus
    Chief Accounting Officer
  • Mark Stach
    General Counsel, Secretary
  • Martin Reid
    Chief Supply Chain Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.